Cargando…
The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTN
Primary ciliary dyskinesia (PCD) is a rare genetic disorder characterised by impaired mucociliary clearance leading to irreversible lung damage. In contrast to other rare lung diseases like cystic fibrosis (CF), there are only few clinical trials and limited evidence-based treatments. Management is...
Ejemplares similares
-
Registries and collaborative studies for primary ciliary dyskinesia in Europe
por: Ardura-Garcia, Cristina, et al.
Publicado: (2020) -
International BEAT-PCD consensus statement for infection prevention and control for primary ciliary dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives
por: Marthin, June K., et al.
Publicado: (2021) -
Motility of efferent duct cilia aids passage of sperm cells through the male reproductive system
por: Aprea, Isabella, et al.
Publicado: (2021) -
Mapping the Most Common Founder Variant in RSPH9 That Causes Primary Ciliary Dyskinesia in Multiple Consanguineous Families of Bedouin Arabs
por: Al-Mutairi, Dalal A., et al.
Publicado: (2023) -
Identification of a novel founder variant in DNAI2 cause primary ciliary dyskinesia in five consanguineous families derived from a single tribe descendant of Arabian Peninsula
por: Al-Mutairi, Dalal A., et al.
Publicado: (2022)